Pfizer CEO Albert Bourla said on Tuesday that he believes it is 'likely' that a strain of COVID-19 could emerge that is resistant to vaccines.
However, the pharmaceuticals boss claimed that the company would be able to develop a new shot to tackle a vaccine-resistant strain within 95 days of its emergence, Fox News reported.
'Every time that a variant appears in the world, our scientists are getting their hands around it,' Bourla said.
'And they are researching to see if this variant can escape the protection of our vaccine. We haven't identified any yet, but we believe that it is likely that one day, one of them will emerge.'
He added: 'We have built a process that within 95 days from the day that we identify a variant as a variant of concern, we will be able to have a vaccine tailor-made against this variant.'
In July, Rochelle Walensky – director of the Centers for Disease Control and Prevention – warned that the coronavirus could mutate and potentially evade vaccines soon.
So-called breakthrough infections among people who've had Pfizer's vaccine – as well as shots from Moderna and Johnson & Johnson have occurred – although they rarely result in serious illness.
However, a virologist at the University of Saskatchewan in Canada told The Telegraph that it was unlikely that the coronavirus could mutate into a vaccine-resistant strain.
'It would require so many mutations in the spike protein that this virus wouldn't 'work' anymore,' Angela Rasmussen said.
Other experts recently blasted a 'fear-mongering' article warning of a 'doomsday' COVID-19 variant which could be worse than Delta.
The doctors emphasized the effectiveness of the jab against the virus and noted that vaccine makers can quickly adjust formulas to make vaccines more effective against variants, Fox News reported.
Their comments come in response to an article in Newsweek Magazine which claimed that the Delta variant has 'shattered' optimism that vaccines would help the pandemic wind down.
The Newsweek Magazine article questioned: 'Is there a Doomsday variant out there that shrugs off vaccines, spreads like wildfire and leaves more of its victims much sicker than anything we've yet seen?'
'The odds are not high that we will see such a triple threat, but experts can't rule it out,' the article reads.
The Newsweek Magazine article appears to draw a number of conclusions, including that the pandemic will continue to get worse and may stick around 'forevermore' – while continuing to mutate.
'The next variant could be Delta on steroids,' warned Michael Osterholm, an epidemiologist.
Osterholm, who leads the Center for Infectious Disease Research and Policy at the University of Minnesota, added that – because of the Delta variant – 'the number of intensive-care beds needed could be higher than any time we've seen.'
He said that an analysis from his team shows that every American who has not been vaccinated or had the disease yet, about 100 million people, will likely get it in the coming months.
News
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]















